TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis.

Eero Polvinen Markus Matilainen Marjo NylundMarcus SucksdorffLaura M Airas

Published in: Neurology(R) neuroimmunology & neuroinflammation (2023)

The results show that single TSPO-PET-based in vivo lesion phenotyping of chronic MS lesions provides a strong predictor for MS disease progression. This emphasizes the significance of chronic active lesions in disability accumulation in MS.

Keyphrases

multiple sclerosis
mass spectrometry
ms ms
pet imaging
white matter
high throughput
positron emission tomography
pet ct
drug induced